Immunologic response to administration of standardized dog allergen extract at differing doses

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 6, 2006, Pages 1249-1256

  Lent, Anne M ^a   Harbeck, Ronald ^a   Strand, Matthew ^b   Sills, Michael ^b   Schmidt, Kimberly ^b   Efaw, Benjamin ^b   Lebo, Terri ^b   Nelson, Harold S ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE

Author keywords

acetone precipitated dog extract; allergen specific IgE; allergen specific IgG 4; Can f 1; cytokine; Immunotherapy; late cutaneous response; skin prick test

Indexed keywords

ALLERGEN; CAN F 1 ALLERGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G4 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACTIVE IMMUNIZATION; ADULT; ALLERGY; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DOMESTIC ANIMAL ALLERGY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; LOW DRUG DOSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MAINTENANCE DRUG DOSE; MULTIPLE DRUG DOSE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ALLERGENS; ANTIBODY SPECIFICITY; CELLS, CULTURED; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN G; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; SKIN TESTS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845219434     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.07.055     Document Type: Article

References (23)

1. Nelson H.S. The use of standardized extracts in allergen immunotherapy. J Allergy Clin Immunol 106 (2000) 31-35
2. Ewbank P., Murray J., Sanders K., Curran-Everett D., Dreskin S., and Nelson H. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract. J Allergy Clin Immunol 111 (2003) 155-161
3. Nanda A., O'Connor M., Anand M., Dreskin S., and Nelson H.S. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J Allergy Clin Immunol 114 (2004) 1339-1344
4. Degroot H., Goei K.G.H., Van Swieten P., and Alberse R.C. Affinity purification of a major and minor allergen from dog extract: serologic activity of affinity-purified Can f 1 and Can f 1-depleted extract. J Allergy Clin Immunol 87 (1991) 1056-1065
5. Meiser J.B., and Nelson H.S. Comparing conventional and acetone-precipitated dog allergen extract skin testing. J Allergy Clin Immunol 107 (2001) 744-745
6. Bousquet J., Lebel B., Khivert H., Bataille Y., Martinot B., and Michel F.B. Nasal challenge with pollen grains, skin-prick test and specific IgE in patients with grass pollen allergy. Clin Allergy 17 (1987) 529-536
7. BD Biosciences Immunocytometry Systems 2004. Available at: http://www.bdbiosciences.com/immunocytometry-systems/htm. Accessed 2004.
8. Creticos P., Van Metre T., Mardiney M., Rosenberg G., Norman P., and Adkinson N. Dose-response of IgE and IgG antibodies during ragweed immunotherapy. J Allergy Clin Immunol 73 (1984) 94-104
9. Conover W.J. Practical nonparametrics statistics (1971), Wiley, New York
10. Hedlin G., Graff-Lonnevig V., Heilbron H., Lilja G., Norrlind K., Pegelow K., et al. Immunotherapy with cat- and dog-dander extracts: effects of 3 years of treatment. J Allergy Clin Immunol 87 (1991) 955-964
11. Lack G., Nelson H.S., Amran D., Oshiba A., Jung T., Bradley K.L., et al. Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells. J Allergy Clin Immunol 99 (1997) 530-538
12. Nish W.A., Charlesworth E.N., Davis T.L., Whisman B.A., Valier S., Charlesworth M.G., et al. The effect of immunotherapy on the cutaneous late phase response to antigen. J Allergy Clin Immunol 93 (1994) 484-493
13. Bousquet J., Maasch H., Martinot B., Hehhaoui A., Wahl R., and Michel F.B. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids: comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 82 (1988) 439-446
14. Des Roches A., Paradis L., Knani J., Hejjaoui A., Dhivert H., Chanez P., et al. Immunotherapy with standardized Dermatophagoides pteronyssinus extract: duration of the efficacy of immunotherapy after its cessation. Allergy 51 (1996) 430-433
15. Gehihar K., Schlaak M., Mecker W.M., and Bufe A. Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome. Clin Exp Allergy 29 (1999) 497-506
16. Nakagawa T., Kozeki H., Katagirir J., Fujita Y., Yamashita N., Miyamoto T., et al. Changes of house dust mite-specific IgE, IgG, and IgG subclasses antibodies during immunotherapy in patients with perennial rhinitis. Int Arch Allergy App Immunol 82 (1987) 95-99
17. Nagaya H. Induction of antigen-specific suppressor cells in patients with hay fever receiving immunotherapy. J Allergy Clin Immunol 75 (1984) 388-394
18. Jutel M., Muller U.R., Fricker M., Rihs S., Pichler W.J., and Dahinden C. Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils. Clin Exp Allergy 26 (1996) 1112-1118
19. Tamir R., Castracane J.M., and Rocklin R.E. Generation of suppressor cells in atopic patients during immunotherapy that modulate IgE synthesis. J Allergy clin Immunol 79 (1987) 591-598
20. Akdis C.A., Blesken T., Akdis M., Wuthrich B., and Blaser K. Role of interleukin-10 in specific immunotherapy. J Clin Invest 102 (1998) 98-106
21. Jutel M., Akdis M., Budak F., Aebischer-Casaulta C., Wrzyszez M., Blaser K., et al. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergen in normal immunity and specific immunotherapy. Eur J Immunol 33 (2003) 1205-1214
22. Antony P.A., and Restifo N.P. Do CD4+CD25+ immunoregulatory T cells hinder tumor immunotherapy?. J Immunother 25 (2002) 202-206
23. Nelson H. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 113 (2004) 635-642